Tirzepatide at its highest approved dose of 15mg produced approximately 22% weight loss, but over a longer 72-week trial period
Overall, food cravings assessed during fasting also decreased with tirzepatide treatment compared with placebo, including cravings for sweets, high-fat food, carbohydrates, starches, and fast-food fats, while cravings for fruits and vegetables were not impacted by tirzepatide treatment
Entinostat, an HDAC inhibitor, has also been recently reported to be able to activate the Wnt signal 19
Lithium Meloxicam can raise lithium levels in the blood, increasing the risk of possible side effects like blurred vision, seizures, kidney problems, shortness of breath, and diarrhea
Transparency in pricing at least allows researchers to make informed comparisons